Accustem Sciences Inc. (ACUT) — 10-Q Filings

10-Q Filings (6)

• Accustem Sciences' Losses Widen Amid R&D Push, Liquidity Concerns Mount — Nov 12, 2025 Risk: high
  Accustem Sciences Inc. (ACUT) reported a net loss of $399,897 for the three months ended September 30, 2025, compared to a net loss of $328,174 for the same per
• Accustem Sciences' Losses Mount Amid R&D Push, Seeks New Capital — Aug 14, 2025 Risk: high
  Accustem Sciences Inc. (ACUT) reported a net loss of $841,811 for the six months ended June 30, 2025, an increase from the $804,827 net loss in the same period
• Accustem Sciences Files Q1 2025 10-Q — May 20, 2025 Risk: low
  Accustem Sciences Inc. filed a 10-Q for the period ending March 31, 2025. The company, formerly known as AccuStem Sciences Ltd, is incorporated in Delaware and
• Accustem Sciences Files Q3 2024 10-Q — Nov 18, 2024 Risk: medium
  Accustem Sciences Inc. filed its 10-Q for the period ending September 30, 2024. The filing covers the third quarter and the first nine months of the fiscal year
• Accustem Sciences Files Q2 2024 10-Q — Sep 16, 2024 Risk: medium
  Accustem Sciences Inc. filed its 10-Q for the period ending June 30, 2024. The company, incorporated in Delaware and operating in Pharmaceutical Preparations, r
• Accustem Sciences Files 10-Q for Q1 2024 — May 20, 2024 Risk: low
  Accustem Sciences Inc. filed its 10-Q for the period ending March 31, 2024. The company, formerly known as AccuStem Sciences Ltd, is incorporated in Delaware an

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX